MediPharm Labs Corp.
LABS.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.51% | 4.62% | -14.81% | -24.91% | -25.75% |
| Total Receivables | -51.91% | -59.19% | -53.14% | -53.77% | 2.96% |
| Inventory | -11.60% | -17.95% | 19.12% | 30.31% | 11.81% |
| Prepaid Expenses | -25.55% | -32.34% | -- | -5.41% | -48.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.73% | 9.72% | -47.48% | 110.12% | -69.72% |
| Total Current Assets | -16.94% | -21.44% | -21.68% | -20.70% | -18.95% |
|
|
|||||
| Total Current Assets | -16.94% | -21.44% | -21.68% | -20.70% | -18.95% |
| Net Property, Plant & Equipment | -22.17% | -25.12% | 38.70% | 43.00% | 37.91% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -16.52% | 3.10% | 2,493.95% | 2,613.19% | 2,562.88% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -17.78% | -21.25% | -1.38% | 0.05% | -3.10% |
|
|
|||||
| Total Accounts Payable | 45.03% | -31.12% | 51.36% | -38.32% | -33.46% |
| Total Accrued Expenses | -3.78% | -18.81% | -0.97% | 36.82% | 82.16% |
| Short-term Debt | -76.78% | 172.39% | 1,408.26% | 312.50% | 140.83% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -73.02% | -58.42% | 15.88% | 65.34% | 123.05% |
| Total Finance Division Other Current Liabilities | -35.27% | -7.64% | -4.89% | -0.19% | -19.29% |
| Total Other Current Liabilities | -35.27% | -7.64% | -4.89% | -0.19% | -19.29% |
| Total Current Liabilities | -15.33% | -7.06% | 35.29% | 17.73% | 20.63% |
|
|
|||||
| Total Current Liabilities | -15.33% | -7.06% | 35.29% | 17.73% | 20.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -76.78% | 172.39% | 1,408.26% | 312.50% | 140.83% |
| Capital Leases | -55.65% | -35.16% | 221.80% | 107.97% | 60.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -15.58% | -18.46% | 35.69% | 18.06% | 20.82% |
|
|
|||||
| Common Stock & APIC | 0.61% | -2.72% | 4.71% | 7.30% | 6.28% |
| Retained Earnings | -7.01% | -4.45% | -8.07% | -10.68% | -14.73% |
| Treasury Stock & Other | 3.02% | 0.10% | 2.08% | 6.43% | 26.77% |
| Total Common Equity | -18.29% | -21.94% | -7.17% | -3.01% | -7.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.29% | -21.94% | -7.17% | -3.01% | -7.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.29% | -21.94% | -7.17% | -3.01% | -7.36% |
|
|
|||||
